Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Indirect comparison of aflibercept with ranibizumab prn and bevacizumab prn in wet age-related macular degeneration.
Third-party funded project
Project title Indirect comparison of aflibercept with ranibizumab prn and bevacizumab prn in wet age-related macular degeneration.
Principal Investigator(s) Bucher, Heiner
Organisation / Research unit Departement Klinische Forschung / Klinische Epidemiologie (Bucher H)
Project start 01.08.2011
Probable end 31.12.2011
Status Completed
Abstract Project which aims to assess in a first step whether an indirect comparison of aflibercept with ranibizumab prn and bevacizumab prn in wet age-related macular degeneration is feasible. If an indirect is feasible based on the data available a network analysis will be performed in a second step.
Financed by Other sources
   

MCSS v5.8 PRO. 0.672 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
05/05/2024